Meyers JD, Flournoy N, Thomas DE. Infection with herpes simplex virus and cell-mediated immunity after marrow transplant. J Infect Dis. 1980;142:338–46.
Article CAS PubMed Google Scholar
Saral R, Burns WH, Laskin OL, Santos GW, Lietman PS. Acyclovir prophylaxis of herpes-simplex-virus infections. N Engl J Med. 1981;305:63–67.
Article CAS PubMed Google Scholar
Gluckman E, Lotsberg J, Devergie A, Zhao XM, Gomez-Morales, Nebout T, et al. Prophylaxis of herpes infections after bone-marrow transplantation by oral acyclovir. Lancet. 1983;2:706–8.
Article CAS PubMed Google Scholar
CDC. Guidelines for preventing opportunistic infections among hematopoietic stem cell transplant recipients. MMWR Recomm Rep. 2000;49:1–25. (RR-10)CE121-127.
National Comprehensive Cancer Network (NCCN) Clinical Practice Guidelines in Oncology. Prevention and treatment of cancer-related infections. Version 2.2023. http://www.nccn.org (Accessed on Feb 09, 2024).
Wade JC, Newton B, Flournoy N, Meyers JD. Oral acyclovir for prevention of herpes simplex virus reactivation after marrow transplantation. Ann Intern Med. 1984;100:823–8.
Article CAS PubMed Google Scholar
Yahav D, Gafter-Gvili A, Muchtar E. Antiviral prophylaxis in haematological patients: systematic review and meta-analysis. Eur J Cancer. 2009;45:3131–48.
Erard V, Wald A, Corey L, Leisenring WM, Boeckh M. Use of long-term suppressive acyclovir after hematopoietic stem-cell transplantation: impact on herpes simplex virus (HSV) disease and drug-resistant HSV disease. J Infect Dis. 2007;196:266.
Article CAS PubMed Google Scholar
Baumrin E, Cheng MP, Kanjilal S, Ho VT, Issa NC, Baden LR. Severe herpes zoster requiring intravenous antiviral treatment in allogeneic hematopoietic cell transplantation recipients on standard acyclovir prophylaxis. Biol Blood Marrow Transpl. 2019;25:1642–7.
Uhlin M, Stikvoort A, Sundin M, Mattsson J. Risk factors and clinical outcome for herpes simplex virus reactivation in patients after allogeneic hematopoietic stem cell transplantation. Biol Blood Marrow Transpl. 2015;21:S170.
Tomblyn M, Chiller T, Einsele H, Gress R, Sepkowitz K, Storek J. Guidelines for preventing infectious complications among hematopoietic cell transplantation recipients: a global perspective. Biol Blood Marrow Transpl. 2009;15:1143–238. https://doi.org/10.1016/j.bbmt.2009.06.019.
Alzahrani M, Damlaj M, Jeffries N, Alahmari B, Singh A, Rondelli D, et al. Non-myeloablative human leukocyte antigen-matched related donor transplantation in sickle cell disease: outcomes from three independent centres. Br J Haematol. 2021;192:761–8. https://doi.org/10.1111/bjh.17311.
留言 (0)